Maneki Docs
Website
  • Maneki
  • About
    • Vision
    • Values
    • Team
    • Mission
  • Use Cases
    • Why Maneki
    • For Patients
    • For Researchers
  • Innovations
    • Proof of Medical Condition
    • mDAO - Disease Specific DAOs
    • MDAO - Equitable Mega Fund
  • Fundamentals
    • Incentive Differentiation Model
    • Enhanced Funding
    • Collaborative Tools
  • FAQ
    • Frequently Asked Questions
Powered by GitBook
On this page

Was this helpful?

  1. FAQ

Frequently Asked Questions

If you have any additional questions, please reach out to pepi@maneki.xyz

How does it work?
  • Community. Patients and researchers join forces to create their own Digital Collectives the community of particular soulbound $<DISEASE_NAME> token holders

  • Propose. United, members of the community can create proposals and vote on them to decide what study to fund next

  • Develop. Patients and researchers use money donated to perform drug development work. This includes clinical trials, pre-clinical development, and manufacturing, to name a few.

  • Sustain. As treatments and cures are commercialized or licensed by other pharmaceutical companies, they return capital to the Patient/Researcher Collectives allowing the community to continue progressing science and fund future projects

What is decentralized science and how does it differ from the current research system?

Decentralized science refers to a system of conducting and sharing scientific research that is decentralized, or not controlled by a central authority. This means that researchers from different institutions or organizations can collaborate and share data in a decentralized manner, without the need for a central authority to oversee the process. In contrast, the current research system is often centralized, with researchers needing to go through a central authority or organization to access data and information from other institutions. Decentralized science aims to address some of the challenges of the current system, such as duplication of effort, lack of collaboration, slower scientific progress, bias, and fraud, by enabling more open and transparent sharing of data and information.

How does decentralized science address the challenges of the current research system, such as duplication of effort, lack of collaboration, slower scientific progress, bias, and fraud?

Decentralized science has the potential to address these challenges by allowing for more open and transparent sharing of data and information. By enabling researchers from different institutions to collaborate and share data in a decentralized manner, decentralized science can help to reduce duplication of effort and increase the efficiency of the research process. In addition, the transparency and openness of decentralized science can help to reduce the risk of bias and fraud, and can ultimately lead to more reliable and robust scientific findings.

How does Maneki enable researchers to collaborate and share data in a decentralized manner, and how does this help to increase the efficiency of the research process?

Maneki is a decentralized science platform that enables researchers from different institutions to collaborate and share data in a decentralized manner. This means that researchers can access data and information from other institutions directly, without the need for a central authority to oversee the process. By enabling more open and transparent sharing of data and information, Maneki can help to reduce duplication of effort and increase the efficiency of the research process.

How does Maneki promote diversity and inclusivity in scientific research?

Maneki can promote diversity and inclusivity in scientific research by lowering barriers to entry for researchers. By enabling researchers from different institutions to collaborate and share data in a decentralized manner, Maneki can help to reduce the need for researchers to go through a central authority or organization to access data and information. This can make it easier for researchers from diverse backgrounds and institutions to participate in scientific research and contribute their knowledge and expertise.

How does Maneki ensure research integrity and transparency, and how does this help to improve the reliability and credibility of scientific research?

Maneki ensures research integrity and transparency by enabling more open and transparent sharing of data and information. By allowing researchers from different institutions to collaborate and share data in a decentralized manner, Maneki can help to reduce the risk of bias and fraud, and can ultimately lead to more reliable and robust scientific findings.

How is the research-ecosystem on Maneki more inclusive for all stakeholders compared to the current research system?

The research-ecosystem on Maneki is more inclusive for all stakeholders compared to the current research system because it allows for more open and transparent sharing of data and information. By enabling researchers from different institutions to collaborate and share data in a decentralized manner, Maneki can help to reduce duplication of effort and increase the efficiency of the research process. In addition, the transparency and openness of decentralized science can help to reduce the risk of bias and fraud, and can ultimately lead to more reliable and robust scientific findings.

What are Soul-bound tokens?

The Soul-bound in SBTs describes a mechanic in which the token is forever bound or linked to a particular account on the blockchain. Maneki plans to use the properties of Soulbound to make sure that researchers and patients can retain voting power and ownership while making it impossible to do a hostile takeover of the Patient/Researcher Collective(s) by buying all the governance tokens. With Maneki there is no governance token you can buy.

Are Digital Collectives DAOs?

Digital Collective are very similar to DAOs in the sense that they operate on a blockchain, group members together around a shared objective, and operate in a decentralized and uncensorable manner. However, Maneki particularly designed Digital Collectives

What is a quadratic funding model?

Quadratic funding is an enhanced crowdfunding mechanism that is designed to reward contributions in proportion to their impact on a given project or community. It is based on the idea that small contributions from a large number of people can have a significant impact on a project, and that these contributions should be recognized and rewarded accordingly. Thus, it is a more democratic and scalable form of matching funding for public goods, i.e. any projects valuable to large groups of people and accessible to the general public.

Why does Maneki organize Patient Collectives better than Facebook?
  • Limited control: Facebook groups are owned and controlled by Facebook, which means that the organization has limited control over the content and functionality of the group.

  • Limited reach: Facebook's algorithms(prioritize ad spend) prioritize content from companies who pay for ads over content from non-paying organizations, which means that it can be difficult for patient advocacy organizations to reach a large audience on the platform.

  • Limited features: While Facebook groups do have some features that can be useful for patient advocacy organizations, such as the ability to create events and polls, they do not offer the same level of functionality as other platforms specifically designed for organizations.

  • Enhanced control, more reach, tailored feature, owned by the Community not by Facebook allowing patients to take control over their communication channels.

How does Maneki make money?
  • Maneki takes a 0.5% free of all transactions in the smart contract protocol and they get sent to Maneki’s Digital Collective Consortium contract which at the end of each month uses a quadratic funding model to redistribute the funds back into the Patient/Researcher Digital Collectives comprising it. Through this Maneki is able to both provide an equitable playing field for funding opportunities as well as pay for servers and technology creation. Once Maneki’s technological costs are covered, the rest of the funds go right back into the Patient/Researcher Digital Collective(s).

  • Maneki will never sell tokens directly to patients, researchers or anyone. Patients and Researchers will never have to spend money in order to be a part of the collective unlike other solutions. Patients and researchers themselves will have the authority and power to create a monetary token to sell to biopharma for investment. As a result of designing the system this way, Maneki is directly incentivized to produce cures/treatments as it is the only way Maneki plans to make any profitable return.

  • Mankei will also have a set of premium features for extreme power users of its platform. Power users will be able to increase their limits on feature usage such as being able to translate 100 papers from English to French every month, as opposed to the 10 free translations afforded to all non-power users.

PreviousCollaborative Tools

Last updated 2 years ago

Was this helpful?